Priority topics

This page contains deadlines and the priority topics for the ERS Congress 2025, which will take place in Amsterdam, Netherlands from 27 September to 1 October, 2025.

Check the session types web page for details on what is included in the Congress programme.

Congress deadlines 2025

Amsterdam 2025 – Symposia

Submissions | 24 June, 2024 – 18 September, 2024

Submission is now open

Vienna 2025 – Hot topics

Submissions | 16 December, 2024 – 17 March, 2025

Priority topics for 2025

The theme for ERS Congress 2025 is:

Respiratory health around the globe

- Global burden of disease from infancy to the elderly ​
- Challenges in respiratory health worldwide, differences and similarities​
- Global solutions to improve respiratory health​

The ERS Congress 2025 programme will extensively cover the latest advances in research and clinical practice, covering following topics and professional specialties:

Respiratory clinical care and physiology

Areas covered will include:

  • Novel techniques to evaluate exertional breathlessness
  • Evaluation of diaphragm dysfunction and treatment modalities
  • Utilizing the Real-World Digital Data to Enhance Respiratory Patient Care
  • What do pulmonary clinicians need to know about sports repeated breathing issues?
  • Lung sounds analysis (early detection of exacerbations)
  • Transitioning to the Responsible AI in Respiratory Care: Building Trust, Enhancing Digital Skills
  • Pulmonary toxicity in newer oncology drugs particularly immune therapy

Respiratory intensive care

Areas covered will include:

  • End-of-life care in acute and chronic mechanical ventilation
  • Phenotyping of ARDS and individualized therapy
  • Diagnostic and treatment of severe CAP and ARDS
  • Mobilization and Rehab: from ICU to home-care
  • Severe acute exacerbation of COPD: from ED to ICU

Basic and translational sciences

Areas covered will include:

  • Cell to Cell Interactions/crosstalk in lung physiology and disease
  • The Lung: A Dynamic Interface with the Environment
  • Origins of Diseases: from genetics to environmental effects
  • Lung Development and Aging
  • The latest from the lab: Paving the Way for Therapeutic Breakthroughs

Sleep disordered breathing

Areas covered will include:

  • How variability affects diagnosis and treatment outcomes in OSA in clinical practice and in clinical trials
  • Central sleep apnoea – from pathophysiology over phenotypes to treatment recommendations
  • Sex differences in sleep-disordered breathing
  • Integrating evidence from different study designs to understand long-term outcomes in OSA and in CSA
  • Personalised management of sleep-disordered breathing in obesity across the lifespan

Airway diseases, asthma, COPD and chronic cough

Areas covered will include:

  • Severe asthma; mucus plugs: from pathophysiology to diagnosis and clinical implications
  • Combining biologics for airway diseases, asthma, and COPD
  • Small molecules targeting airway diseases; moving therapeutics toward future
  • Preventing the journey towards severe asthma
  • Cough phenotyping: from the clinic to the treatment
  • System biology in airway diseases; looking into big data to find answers for asthma and COPD

Epidemiology and environment

Areas covered will include:

  • Lung trajectories and lifetime exposures and disease development across the globe
  • Environmental and occupational respiratory challenges: the view from the global south.
  • Interventions in the face of occupational, environmental and lifestyle challenges
  • Tobacco and its environmental impact
  • Future city visions for better respiratory health
  • Prevention in respiratory health through smoking cessation and vaccinations

Paediatrics

Areas covered will include:

  • Infections (asthma, PCD/bronchiectasis, CF): long term outcomes
  • Diversities of different diseases (Prematurity and related respiratory disorders; Asthma; Respiratory Infections)
  • Global solutions to improve respiratory health: identification of risks (biomarkers/phenotypes); vaccination; disease observatories
  • Early roots of COPD: chronic lung disease of prematurity, impact of childhood disadvantage factors
  • Challenges in respiratory health worldwide: different priorities in different settings – smoking, air pollution, vaping

Thoracic surgery and transplantation

Areas covered will include:

  • Lung as a victim of humoral immunity
  • Post-transplant viral infections
  • Induction treatment in NSCLC
  • Different surgical approaches to bilateral lung Tx
  • AI and CT imaging in the evolution of solitary pulmonary nodules

Allied respiratory professionals

Areas covered will include:

  • Understanding and managing dyspnoea: a multidimensional perspective
  • Exercise-training in severely impaired patients
  • Supporting behaviour change in chronic respiratory disease
  • Co-design and patient involvement in respiratory innovation
  • Self-management of chronic respiratory diseases

Respiratory infections

Areas covered will include:

  • Respiratory infections diagnostics
  • Biomarkers in respiratory infections
  • NTM – how long is enough when there is no response
  • Antimicrobial resistance
  • Global health in respiratory infections

Thoracic oncology

Areas covered will include:

  • 9th TNM edition for LC staging
  • Early stage Lung Cancer, peri-operative management and ablative treatment alternatives
  • Severe respiratory comorbidities affecting treatment decisions in early stages of LC
  • Lung Cancer Screening update (eg. SOLACE/OPTIMA/IDERHA)
  • The updated (9th Edition) of the TNM staging system for mesothelioma; practical implications

Interstitial lung diseases

Areas covered will include:

  • Infections in ILD – consequence or driver of fibrosis ?
  • Disappointments and new hopes for IPF & PPF therapies
  • Pheno- and Endotypes in ILD
  • ILA and screening for ILD
  • Sarcoidosis 2025

Pulmonary vascular diseases

Areas covered will include:

  • Novel therapies in PAH
  • PH and comorbidities
  • Chronic thromboembolic disease
  • Treatment decisions in acute pulmonary embolism patients at high risk
  • Genetic phenotypes (icon groups)
  • Radiology of pulmonary vascular disease

Clinical techniques, imaging and endoscopy

Areas covered will include:

  • Lung nodules over the world: diagnosis, aetiology and treatment
  • New invasive interventional procedures
  • Management of complications of interventional procedures
  • Diagnosis and treatment of pleural disease
  • New developments in therapeutic bronchoscopy: COPD/chronic bronchitis

Contact us

Do you have questions about the Congress programme or session proposals?

Get in touch